Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00250640
First received: November 7, 2005
Last updated: January 30, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)